- RELX plc
- 24 April 2025 08:41:31
Source: Sharecast
The global firm, which provides information-based analytics and decision tools to professionals businesses, said underlying revenues had grown in all four of its divisions.
In risk, which accounts for 34% of group sales, strong revenue growth had been driven largely by financial crime compliance and by digital fraud and identity.
In its scientific, technical and medical unit, Relx’s second-biggest division, the jump in revenues was attributed to “the evolution of the business mix”.
Relx said: “The full-year outlook is unchanged.
“We continue to see positive momentum across the group, and we expect another year of strong underlying growth in revenue and adjusted operating profit, as well as strong growth in adjusted earnings per share on a constant currency basis.”
As at 0830 BST, the blue chip’s London-listed shares were up 1% at 3,965p. The company, which employs around 36,000 people across more than 180 countries, is also listed in Amsterdam and New York.
Relx, formerly known as Reed Elsevier, was updating investors ahead of its annual general meeting. Its year end is 31 December 2025.